EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Innovations in Cutaneous Lupus

Rachel R Lin, Peyton V Warp, Mara A Hartoyo, Scott A Elman, Andrea D Maderal

Dermatologic Clinics · 2025

DOI: 10.1016/j.det.2024.08.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Dermatologic Clinics, 2025. Verfasst von Rachel R Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Miami Miller School of Medicine, 1120 Northwest 14th Street, Suite 9, Miami, FL 33136, USA. Electronic addre…. Hauptthemen laut MEDLINE: Lupus Erythematosus, Cutaneous, Immunosuppressive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 99 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous lupus erythematosus (CLE) is an autoimmune-mediated skin disease under the family of lupus erythematosus. Systemic immunosuppressants and topical treatments have been used to manage CLE; however, these treatments tend to be moderately efficacious and leave patients with unmet therapeutic needs. There is a need for medications that target pruritus, scarring, dyspigmentation, and other symptoms of chronic CLE that contribute to decreased quality of life. The introduction of new biologics and other systemic medications has expanded dermatologists' and rheumatologists' ability to manage CLE. This article discusses new pharmaceuticals and guidelines providing an updated overview of the clinical management of CLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, CutaneousImmunosuppressive AgentsHumansBiological ProductsDermatologic AgentsAntibodies, Monoclonal, HumanizedHydroxychloroquineRituximabPiperidinesPyrimidines

Stichwörter der Autor:innen

Biological therapiesClinical trial overviewConnective tissue diseaseCutaneous lupus erythematosus

Substanzen

Immunosuppressive AgentsBiological ProductsDermatologic AgentsAntibodies, Monoclonal, HumanizedbelimumabtofacitinibHydroxychloroquineRituximabPiperidinesPyrimidines

Autor:innen und Institutionen

  • Department of Dermatology, University of Miami Miller School of Medicine, 1120 Northwest 14th Street, Suite 9, Miami, FL 33136, USA. Electronic address: rachel.lin@med.miami.edu.
  • Department of Dermatology, University of Miami Miller School of Medicine, 1120 Northwest 14th Street, Suite 9, Miami, FL 33136, USA.
  • Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, 1120 Northwest 14th Street, Suite 9, Miami, FL 33136, USA.

Zitieren

APA

Lin, R. R., Warp, P. V., Hartoyo, M. A., Elman, S. A., & Maderal, A. D. (2025). Innovations in Cutaneous Lupus. Dermatologic Clinics. https://doi.org/10.1016/j.det.2024.08.010

Vancouver

Lin RR, Warp PV, Hartoyo MA, Elman SA, Maderal AD. Innovations in Cutaneous Lupus. Dermatologic Clinics. 2025. doi:10.1016/j.det.2024.08.010

BibTeX
@article{Lin2025,
  author = {Lin, Rachel R and Warp, Peyton V and Hartoyo, Mara A and Elman, Scott A and Maderal, Andrea D},
  title = {Innovations in Cutaneous Lupus},
  journal = {Dermatologic Clinics},
  year = {2025},
  doi = {10.1016/j.det.2024.08.010}
}
Kostenlos starten →